BSE filing, NSE: JINDALSTEL. Summary written from the filing by ALFA Finder's alert engine.
Jindal Steel Ltd: key numbers
- Share price
- ₹1,048.10
- Market cap
- ₹1,06,915 Cr
- Revenue (annual)
- ₹53,225 Cr
- Net profit (annual)
- ₹3,367 Cr
- P/E (TTM)
- 37.5×Sector 16.9×
- Promoter holding
- 62.69%+0.00% QoQ
- FII holding
- 8.75%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jindal Steel Ltd
All →Jindal Steel Investor Presentation: Key Takeaways
Q2FY27 gross revenue ₹19,448 cr, adj. EBITDA ₹2,504 cr, PAT ₹771 cr, net debt/EBITDA 1.51x, cash ₹7,237 cr. Deleveraging and capex-led growth continue.
Jindal Steel Q2 FY27 Results: Net Profit ₹770.6 Cr, Up 21.3% YoY
Jindal Steel Ltd reported revenue from operations of ₹16,678 Cr (+42.7% YoY) and net profit of ₹770.6 Cr (+21.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹770.6 Cr · +21.3% YoY
Jindal Steel Other Announcement
Jindal Steel Ltd has filed its quarterly shareholding pattern as mandated by regulation. This is a periodic compliance disclosure.
Jindal Steel Board Meeting Date
Jindal Steel Ltd has scheduled a board meeting for October 23, 2026, to consider and approve its unaudited standalone and consolidated financial results.
Jindal Steel Promoter Buying: ₹9.21 Cr
Promoter group member Sarika Jhunjhnuwala acquired 79,600 equity shares of Jindal Steel via market purchase for ₹9.21 Crore.
- Value
- ₹9.21 Cr
Jindal Steel Promoter Selling: ₹108.2 Cr
Promoter group member Sarika Jhunjhnuwala sold 95,000 equity shares of Jindal Steel Ltd via open market transactions.
- Value
- ₹108.2 Cr
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date